Aubrey M. Schonhoff

Aubrey M. Schonhoff

Auto-generated profile, based on publicly available information

Aubrey M. Schonhoff

University of Alabama at Birmingham

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Experimental Neurology
Verified
Journal Article
Closed access
AHAshley S. Harms
Ashley S. Harms
ATAaron D. Thome
Aaron D. Thome
ZYZhaoqi Yan
Zhaoqi Yan
ASAubrey M. Schonhoff
Aubrey M. Schonhoff
GWGregory P. Williams
Gregory P. Williams
DSDavid Standaert
David Standaert

5 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
EXEnquan Xu
Enquan Xu
RBRavindra Boddu
Ravindra Boddu
HAHisham A. Abdelmotilib
Hisham A. Abdelmotilib
KKKaela Kelly
Kaela Kelly
ASArpine Sokratian
Arpine Sokratian
AWAndrew B. West
Andrew B. West
Missense mutations in the LRRK2 gene that lead to LRRK2 kinase hyperactivity can cause Parkinson’s disease (PD). The link between LRRK2 and α-synuclein aggregation in PD remains enigmatic. Numerous reports suggest critical LRRK2 functions in microglial responses. Herein, we find that LRRK2-positive immune cells in the brain represent CD68-positive pro-inflammatory, monocyte-derived macrophages, distinct from microglia. Rod α-synuclein fibrils stimulate LRRK2 kinase activity in monocyte-derived macrophages, and LRRK2 mutations lead to enhanced recruitment of classical monocytes into the midbrain in response to α-synuclein. LRRK2 kinase inhibition blocks α-synuclein fibril induction of LRRK2 protein in both human and murine macrophages, with human cells demonstrating much higher LRRK2 levels and kinase activity than equivalent murine cells. Further, interferon-γ strongly induces LRRK2 kinase activity in primary human macrophages in comparison to weak effects observed in murine cells. These results highlight peripheral immune responses in LRRK2-linked paradigms that further connect two central proteins in PD.